Cost-Benefit Analysis of the Pigmented Lesion Assay When Introduced Into the Visual Assessment Histopathology Pathway for Lesions Clinically Suspicious for Melanoma. J of Skin 2022, 6 (2), 109-121. https://doi.org/10.25251/skin.6.2.4.